245
Views
79
CrossRef citations to date
0
Altmetric
Research Article

Sildenafil in erectile dysfunction: a critical review

, &
Pages 241-262 | Accepted 10 Mar 2003, Published online: 22 Sep 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Luca Boeri, Paolo Capogrosso, Eugenio Ventimiglia, Alessandro Serino, Giovanni La Croce, Andrea Russo, Rocco Damiano, Francesco Montorsi & Andrea Salonia. (2016) Avanafil - a further step to tailoring patient needs and expectations. Expert Review of Clinical Pharmacology 9:9, pages 1171-1181.
Read now
Eugenio Ventimiglia, Paolo Capogrosso, Francesco Montorsi & Andrea Salonia. (2016) The safety of phosphodiesterase type 5 inhibitors for erectile dysfunction. Expert Opinion on Drug Safety 15:2, pages 141-152.
Read now
E. Fooladi, R. J. Bell & S. R. Davis. (2012) Management strategies in SSRI-associated sexual dysfunction in women at midlife. Climacteric 15:4, pages 306-316.
Read now
Philip G Bardin. (2007) Treatment of obstructive airway diseases with roflumilast, a novel phosphodiesterase 4 inhibitor. Expert Review of Clinical Immunology 3:4, pages 469-476.
Read now
Victoria Boswell-Smith & Clive P Page. (2006) Roflumilast: a phosphodiesterase-4 inhibitor for the treatment of respiratory disease. Expert Opinion on Investigational Drugs 15:9, pages 1105-1113.
Read now

Articles from other publishers (74)

Greta Camilla Magnano, Marika Quadri, Elisabetta Palazzo, Roberta Lotti, Francesca Loschi, Stefano Dall'Acqua, Michela Abrami, Francesca Larese Filon, Alessandra Marconi & Dritan Hasa. (2024) 3D human foreskin model for testing topical formulations of sildenafil citrate. International Journal of Pharmaceutics 649, pages 123612.
Crossref
Jennifer Arcila-Saenz, Gina Hincapié-Mejía, Yudy Andrea Londoño-Cañas & Gustavo A. Peñuela. (2023) Role of the hydrolytic-acidogenic phase on the removal of bisphenol A and sildenafil during anaerobic treatment. Environmental Monitoring and Assessment 195:12.
Crossref
Chin-Yu Shih, Chao-Yi Chen, Hsien-Te Lin, Ying-Ju Liao & Yao-Jen Liang. (2023) Oral Bioavailability and Pharmacokinetics of Sildenafil Orally Disintegrating Tablets under Various Gastric pH Levels Following Administration of Omeprazole in Rats. Life 13:11, pages 2126.
Crossref
Zahraa Kayali, Reem H. Obaydo & Amir Alhaj Sakur. (2023) Spider diagram and sustainability evaluation of UV-methods strategy for quantification of aspirin and sildenafil citrate in the presence of salicylic acid in their bulk and formulation. Heliyon 9:4, pages e15260.
Crossref
Andrea Salonia & Paolo Capogrosso. (2023) Publishing industry–sponsored studies. The Journal of Sexual Medicine 20:4, pages 422-425.
Crossref
Jakob J. Anibas, Nicholas Brady & Naga Suresh Cheppalli. (2023) Association Between Prosthetic Knee Effusions and Phosphodiesterase Type-5 Enzyme Inhibitor Use After Total Knee Arthroplasty. JBJS Case Connector 13:1.
Crossref
Jessica M. Turner, Francesca Russo, Jan Deprest, Ben W. Mol & Sailesh Kumar. (2022) Phosphodiesterase‐5 inhibitors in pregnancy: Systematic review and meta‐analysis of maternal and perinatal safety and clinical outcomes. BJOG: An International Journal of Obstetrics & Gynaecology 129:11, pages 1817-1831.
Crossref
Jessica N. Schardein & James M. Hotaling. (2022) The Impact of Testosterone on Erectile Function. Androgens: Clinical Research and Therapeutics 3:1, pages 113-124.
Crossref
Yu‐Hao Zhao, Ze‐Xiu Wu, Xin Zhao, Jun Jiang & Rui Jiang. (2022) Low androgen level impairs erectile function of rat by regulating the Ng/CaN/AKT/eNOS pathway in penile corpus cavernosum. Andrology 10:6, pages 1189-1196.
Crossref
David B. VoduŠek & Michael J. Aminoff. 2021. Aminoff's Neurology and General Medicine. Aminoff's Neurology and General Medicine 557 576 .
Robert E. Pyke. (2020) Sexual Performance Anxiety. Sexual Medicine Reviews 8:2, pages 183-190.
Crossref
David B. Vodušek. 2020. Suprapontine Lesions and Neurogenic Pelvic Dysfunctions. Suprapontine Lesions and Neurogenic Pelvic Dysfunctions 107 114 .
Amir Hadanny, Erez Lang, Laurian Copel, Oshra Meir, Yair Bechor, Gregory Fishlev, Jacob Bergan, Mony Friedman, Amnon Zisman & Shai Efrati. (2018) Hyperbaric oxygen can induce angiogenesis and recover erectile function. International Journal of Impotence Research 30:6, pages 292-299.
Crossref
Mohammad Reza Safarinejad & Shiva Safarinejad. (2018) WITHDRAWN: Plasma Chitotriosidase Activity and Arteriogenic Erectile Dysfunction: Association with the Presence, Severity, and Duration. The Journal of Sexual Medicine.
Crossref
Srinivasulu Cherukupalli, Girish A. Hampannavar, Sampath Chinnam, Balakumar Chandrasekaran, Nisar Sayyad, Francis Kayamba, Rajeshwar Reddy Aleti & Rajshekhar Karpoormath. (2018) An appraisal on synthetic and pharmaceutical perspectives of pyrazolo[4,3-d]pyrimidine scaffold. Bioorganic & Medicinal Chemistry 26:2, pages 309-339.
Crossref
L. Ozcan, E. C. Polat, R. Kocaaslan, E. Onen, A. Otunctemur & E. Ozbek. (2017) Effects of taking tadalafil 5 mg once daily on erectile function and total testosterone levels in patients with metabolic syndrome. Andrologia 49:9, pages e12751.
Crossref
Bo Ram Choi, Hye Kyung Kim & Jong Kwan Park. (2017) Penile Erection Induced by Scoparone from Artemisia capillaris through the Nitric Oxide-Cyclic Guanosine Monophosphate Signaling Pathway . The World Journal of Men's Health 35:3, pages 196.
Crossref
Nancy S. Saad, Kyle Floyd, Amany A. E. Ahmed, Peter J. Mohler, Paul M. L. Janssen & Mohammad T. Elnakish. (2016) The Effect of Sorafenib, Tadalafil and Macitentan Treatments on Thyroxin-Induced Hemodynamic Changes and Cardiac Abnormalities. PLOS ONE 11:4, pages e0153694.
Crossref
Sunil YounWan-su ParkGab-jin ParkDoo Yeon JangSoo Hyeon BaeSeunghoon HanDong-Seok Yim. (2016) Population pharmacokinetics and inter-laboratory variability of sildenafil and its metabolite after oral administration in Korean healthy male volunteers. Translational and Clinical Pharmacology 24:2, pages 105.
Crossref
. 2016. Meyler's Side Effects of Drugs. Meyler's Side Effects of Drugs 734 742 .
Ruben Vardanyan & Victor Hruby. 2016. Synthesis of Best-Seller Drugs. Synthesis of Best-Seller Drugs 783 800 .
Ramhari V. Rote, Deepak P. Shelar, Sandeep R. Patil & Madhukar N. Jachak. (2014) A Convenient Synthesis of New Pyrazolo[4,3- d ]pyrimidines and Their Fused Heterocycles . Journal of Heterocyclic Chemistry 51:3, pages 815-823.
Crossref
Dany‐Jan Yassin, Aksam A. Yassin & Peter G. Hammerer. (2014) Combined Testosterone and Vardenafil Treatment for Restoring Erectile Function in Hypogonadal Patients who Failed to Respond to Testosterone Therapy Alone. The Journal of Sexual Medicine 11:2, pages 543-552.
Crossref
Alok S Tripathi, Papiya M Mazumder & Anil V Chandewar. (2014) Changes in the pharmacokinetic of sildenafil citrate in rats with Streptozotocin-induced diabetic nephropathy. Journal of Diabetes & Metabolic Disorders 13:1.
Crossref
David B. Vodušek & Michael J. Aminoff. 2014. Aminoff's Neurology and General Medicine. Aminoff's Neurology and General Medicine 633 656 .
Michael D. Berry & Philip D. Berry. (2013) Contemporary Treatment of Sexual Dysfunction: Reexamining the Biopsychosocial Model. The Journal of Sexual Medicine 10:11, pages 2627-2643.
Crossref
Ng Kok Kit. 2013. Men's Health. Men's Health 71 76 .
Gila Bronner & David B. Vodušek. (2011) Management of sexual dysfunction in Parkinson’s disease. Therapeutic Advances in Neurological Disorders 4:6, pages 375-383.
Crossref
Zdenka Bartošová, David Jirovský & Aleš Horna. (2011) High-performance liquid chromatographic method with amperometric detection employing boron-doped diamond electrode for the determination of sildenafil, vardenafil and their main metabolites in plasma. Journal of Chromatography A 1218:44, pages 7996-8001.
Crossref
Jayne C Lucke, Stephanie K Bell, Bradley J Partridge & Wayne D Hall. (2011) Academic doping or Viagra for the brain?. EMBO reports 12:3, pages 197-201.
Crossref
Michael B. Tollefson, Brad A. Acker, E.J. Jacobsen, Robert O. Hughes, John K. Walker, David N.A. Fox, Michael J. Palmer, Sandra K. Freeman, Ying Yu & Brian R. Bond. (2010) 1-(2-Ethoxyethyl)-1H-pyrazolo[4,3-d]pyrimidines as potent phosphodiesterase 5 (PDE5) inhibitors. Bioorganic & Medicinal Chemistry Letters 20:10, pages 3120-3124.
Crossref
Michael B. Tollefson, Brad A. Acker, E.J. Jacobsen, Robert O. Hughes, John K. Walker, David N.A. Fox, Michael J. Palmer, Sandra K. Freeman, Ying Yu & Brian R. Bond. (2010) 1-(2-(2,2,2-Trifluoroethoxy)ethyl-1H-pyrazolo[4,3-d]pyrimidines as potent phosphodiesterase 5 (PDE5) inhibitors. Bioorganic & Medicinal Chemistry Letters 20:10, pages 3125-3128.
Crossref
John P. Mulhall, Rosie King, Dana J. Brimmer, James Harnett, Kyle Hvidsten, Sofia S. Kennedy, Prabashni Reddy, Svetlana Denevich & Chris L. Pashos. (2010) Attitudes, beliefs, and values regarding the sexual experience in men: development of the Sexual Experience Questionnaire. Journal of Men's Health 7:1, pages 20-30.
Crossref
F. Giuliano, G. Jackson, F. Montorsi, A. Martin-Morales & P. Raillard. (2009) Safety of sildenafil citrate: review of 67 double-blind placebo-controlled trials and the postmarketing safety database. International Journal of Clinical Practice 64:2, pages 240-255.
Crossref
Annamarie Moore & Agnes Higgins. (2009) Testicular cancer: addressing the psychosexual issues. British Journal of Nursing 18:19, pages 1182-1186.
Crossref
Mohammad Reza Safarinejad, Ali Asgar Kolahi & Gholamhossein Ghaedi. (2009) Safety and efficacy of sildenafil citrate in treating erectile dysfunction in patients with combat-related post-traumatic stress disorder: a double-blind, randomized and placebo-controlled study. BJU International 104:3, pages 376-383.
Crossref
David B. Vodušek. (2014) Urogenital dysfunction in patients with multiple sclerosis. Acta Neuropsychiatrica 21:S2, pages 22-27.
Crossref
Alan M. Laties. (2009) Vision Disorders and Phosphodiesterase Type 5 Inhibitors. Drug Safety 32:1, pages 1-18.
Crossref
. 2009. MeylerâÂÂs Side Effects of Cardiovascular Drugs. MeylerâÂÂs Side Effects of Cardiovascular Drugs 431 448 .
Andrea Salonia, Alberto Briganti, Andrea Gallina & Francesco Montorsi. 2009. Sexual Function in the Prostate Cancer Patient. Sexual Function in the Prostate Cancer Patient 177 196 .
M. S. Venetikou, T. Lambou & D. Gizani. (2008) Hyperprolactinaemia due to hypothalamic–pituitary disease or drug-induced in patients with erectile dysfunction. Andrologia 40:4, pages 240-244.
Crossref
R. Shabsigh, J.M. Kaufman, C. Steidle & H. Padma-Nathan. (2008) Randomized Study of Testosterone Gel as Adjunctive Therapy to Sildenafil in Hypogonadal Men With Erectile Dysfunction Who Do Not Respond to Sildenafil Alone. Journal of Urology 179:5S.
Crossref
Hayley Matic & Marita P McCabe. (2008) Duration of erectile dysfunction and its relationship to treatment seeking and satisfaction with treatment using PDE5 inhibitors. International Journal of Urology 15:4, pages 346-349.
Crossref
Mohammad Reza Safarinejad & Seyyed Yousof Hosseini. (2008) Salvage of Sildenafil Failures With Bremelanotide: A Randomized, Double-Blind, Placebo Controlled Study. Journal of Urology 179:3, pages 1066-1071.
Crossref
Imre Kovács, Albert Császár, Janos Toth, György Siller, Attila Farkas, Jenő Tarján, Judit Horváth & Akos Koller. (2008) Correlation Between Flow-Mediated Dilation and Erectile Dysfunction. Journal of Cardiovascular Pharmacology 51:2, pages 148-153.
Crossref
David B. VoduŠEk & Michael J. Aminoff. 2008. Neurology and General Medicine. Neurology and General Medicine 651 672 .
Christian Stief. (2007) Testosterone and Erection: Practical Management for the Patient with Erectile Dysfunction. European Urology Supplements 6:17, pages 868-873.
Crossref
Andrea Salonia. (2007) Sildenafil citrate: a safe and effective treatment for erectile dysfunction after renal transplantation?. Nature Clinical Practice Nephrology 3:2, pages 80-81.
Crossref
Linda Wagner & Charlotte Kenreigh. 2007. xPharm: The Comprehensive Pharmacology Reference. xPharm: The Comprehensive Pharmacology Reference 1 4 .
M R Safarinejad. (2006) Salvage of sildenafil failures with cabergoline: a randomized, double-blind, placebo-controlled study. International Journal of Impotence Research 18:6, pages 550-558.
Crossref
Emanuela A. Greco, Giovanni Spera & Antonio Aversa. (2006) Combining Testosterone and PDE5 Inhibitors in Erectile Dysfunction: Basic Rationale and Clinical Evidences. European Urology 50:5, pages 940-947.
Crossref
Ilan Gruenwald, Ofer Shenfeld, Juza Chen, Gil Raviv, Santiago Richter, Ayala Cohen & Yoram Vardi. (2006) Positive Effect of Counseling and Dose Adjustment in Patients with Erectile Dysfunction who Failed Treatment with Sildenafil. European Urology 50:1, pages 134-140.
Crossref
Dmitri Pissarnitski. (2006) Phosphodiesterase 5 (PDE 5) inhibitors for the treatment of male erectile disorder: Attaining selectivity versus PDE6. Medicinal Research Reviews 26:3, pages 369-395.
Crossref
A. A. Yassin, F. Saad & H. E. Diede. (2006) Testosterone and erectile function in hypogonadal men unresponsive to tadalafil: results from an open-label uncontrolled study. Andrologia 38:2, pages 61-68.
Crossref
Brian D. Rosenthal, Noah R. May, Michael J. Metro, Richard C. Harkaway & Phillip C. Ginsberg. (2006) Adjunctive use of AndroGel (testosterone gel) with sildenafil to treat erectile dysfunction in men with acquired androgen deficiency syndrome after failure using sildenafil alone. Urology 67:3, pages 571-574.
Crossref
Seung Hyun Cho, Hyojin Park, Jung Hwan Kim, Young Hoon Ryu, Sang In Lee & Jeffrey L Conklin. (2006) Effect of sildenafil on gastric emptying in healthy adults. Journal of Gastroenterology and Hepatology 21:1, pages 222-226.
Crossref
Ricardo Munarriz, Noel N. Kim, Irwin Goldstein & Abdul M. Traish. 2006. Vascular Medicine. Vascular Medicine 395 410 .
BILJANA MUSICKI, HUNTER C. CHAMPION, ROBYN E. BECKER, MELISSA F. KRAMER, TONGYUN LIU, SENA F. SEZEN & ARTHUR L. BURNETT. (2005) IN VIVO ANALYSIS OF CHRONIC PHOSPHODIESTERASE-5 INHIBITION WITH SILDENAFIL IN PENILE ERECTILE TISSUES: NO TACHYPHYLAXIS EFFECT. Journal of Urology 174:4 Part 1, pages 1493-1496.
Crossref
Nancy F. Crum, Kari J. Furtek, Patrick E. Olson, Christopher L. Amling & Mark R. Wallace. (2005) A Review of Hypogonadism and Erectile Dysfunction Among HIV-Infected Men During the Pre- and Post-HAART Eras: Diagnosis, Pathogenesis, and Management. AIDS Patient Care and STDs 19:10, pages 869-885.
Crossref
Nancy F. CrumKari J. FurtekPatrick E. OlsonChristopher L. AmlingMark R. Wallace. (2005) A Review of Hypogonadism and Erectile Dysfunction Among HIV-Infected Men During the Pre- and Post-HAART Eras: Diagnosis, Pathogenesis, and Management. AIDS Patient Care and STDs 19:10, pages 655-671.
Crossref
Riadh Daghfous, Sihem El Aidli, Ahmed Zaiem, Mohamed Hedi Loueslati & Chelbi Belkahia. (2005) Sildenafil-Associated Hepatotoxicity. The American Journal of Gastroenterology 100:8, pages 1895-1896.
Crossref
Laszlo Revesz, Ernst Blum & Reto Wicki. (2005) Synthesis of novel piperazine based building blocks: 3,7,9-triazabicyclo[3.3.1]nonane, 3,6,8-triazabicyclo[3.2.2]nonane, 3-oxa-7,9-diazabicyclo[3.3.1]nonane and 3-oxa-6,8-diazabicyclo[3.2.2]nonane. Tetrahedron Letters 46:33, pages 5577-5580.
Crossref
Biljana Musicki, Hunter C. Champion, Robyn E. Becker, Tongyun Liu, Melissa F. Kramer & Arthur L. Burnett. (2005) Erection Capability Is Potentiated by Long-Term Sildenafil Treatment: Role of Blood Flow-Induced Endothelial Nitric-Oxide Synthase Phosphorylation. Molecular Pharmacology 68:1, pages 226-232.
Crossref
Andrea Salonia, Luigi Barbieri, Juza Chen, Alberto Briganti, Federico Dehò, Richard Naspro, Ubaldo Del Carro, Kostantinos Rokkas, Vincenzo Scattoni, Patrizio Rigatti & Francesco Montorsi. (2005) Comparison of the Effect of Sildenafil and Apomorphine SL on Nocturnal Erections in Healthy Volunteers: A Placebo-Controlled Study. European Urology 47:4, pages 524-529.
Crossref
Andrea Salonia, Alberto Briganti, Piero Montorsi, Tommaso Maga, Federico Deh??Giuseppe Zanni, Bruno Mazzoccoli, Nazareno Suardi, Patrizio Rigatti & Francesco Montorsi. (2005) Safety and Tolerability of Oral Erectile Dysfunction Treatments in the Elderly. Drugs & Aging 22:4, pages 323-338.
Crossref
Jasjit S. Kalsi, David J. Ralph, Phil Thomas, James Bellringer, Suks Minhas, Phil D. Kell & Selim Cellek. (2005) ORIGINAL RESEARCH—BASIC SCIENCE: A Nitric Oxide‐Releasing PDE5 Inhibitor Relaxes Human Corpus Cavernosum in the Absence of Endogenous Nitric Oxide. The Journal of Sexual Medicine 2:1, pages 53-57.
Crossref
R. Verhaeghe. 2005. Side Effects of Drugs Annual 28. Side Effects of Drugs Annual 28 223 225 .
Daniela Giordano, Mauro Giorgi, Ada Maria Tata, Anna Modica & Gabriella Augusti‐Tocco. (2004) Expression of PDE5 splice variants during ontogenesis of chick dorsal root ganglia. Journal of Neuroscience Research 78:6, pages 815-823.
Crossref
Francesco Montorsi, Jackie Corbin & Stephen Phillips, PhD. (2004) REVIEW: Review of Phosphodiesterases in the Urogenital System: New Directions for Therapeutic Intervention. The Journal of Sexual Medicine 1:3, pages 322-336.
Crossref
R. SHABSIGHJ.M. KAUFMANC. STEIDLEH. PADMA-NATHAN. (2004) RANDOMIZED STUDY OF TESTOSTERONE GEL AS ADJUNCTIVE THERAPY TO SILDENAFIL IN HYPOGONADAL MEN WITH ERECTILE DYSFUNCTION WHO DO NOT RESPOND TO SILDENAFIL ALONE. Journal of Urology 172:2, pages 658-663.
Crossref
Frank Sommer & Udo Engelmann. (2004) Future Options for Combination Therapy in the Management of Erectile Dysfunction in Older Men. Drugs & Aging 21:9, pages 555-564.
Crossref
Matthias J. Müller. 2004. Sildenafil. Sildenafil 83 100 .
Sharron H. Francis & Jackie D. Corbin. 2004. Sildenafil. Sildenafil 15 33 .
Alison Woodcock & Clare Bradley. 2014. Cambridge Handbook of Psychology, Health and Medicine. Cambridge Handbook of Psychology, Health and Medicine 670 673 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.